StockWatch
·

SRF LTD. Q3 FY26 Results

SRFQ3 FY26 Results
Filing
MetricValue (₹ Cr)Q2 FY26Q3 FY25
Revenue3.7K2.0%6.3%
Total Income3.7K2.0%5.9%
Expenditure3.2K2.1%1.7%
PBT451.6712.6%22.5%
Net Profit432.6611.5%59.6%
OPM19.04%2.23pp17.94pp
NPM11.57%0.98pp3.89pp
EPS14.6011.4%59.6%
View full financials

SRF Limited Posts Solid Q3FY26 Results Driven by Strong Chemicals Business Momentum

20 Jan 2026 · 20 Jan, 3:28 pm

Summary

SRF Limited, a chemical based multi-business entity, announced its consolidated financial results for the third quarter and nine months ended December 31, 2025. The Company's revenue increased by 6%, EBIT by 23%, and Profit after Tax (PAT) by 60% compared to the corresponding period last year.

Key Highlights

  1. 1

    Consolidated revenue increased 6% to ₹3,713 crore in Q3FY26

  2. 2

    EBIT increased 23% to ₹7,653 crore in Q3FY26

  3. 3

    PAT increased 60% to ₹4,330 crore in Q3FY26

  4. 4

    Chemicals Business reported an increase of 22% in segment revenue

  5. 5

    Fluorochemicals Business delivered a record quarter

  6. 6

    Specialty Chemicals Business saw muted quarterly performance

  7. 7

    Performance Films & Foil Business reported a decline of 3% in segment revenue

  8. 8

    Technical Textiles Business reported a decline of 11% in segment revenue

  9. 9

    Other Businesses reported a decline of 9% in segment revenue

  10. 10

    Company's revenue increased 8% and PAT increased 73% in 9M FY26

  11. 11

    Additional gratuity and leave liability of ₹773 crore recognized in Q3FY26

  12. 12

    Board approved the establishment of a new Pharma Intermediates Plant facility at Dahej with an estimated investment of ₹180 crore

Management Comments

A

Ashish Bharat Ram

On an overall basis, this has been a good quarter for the Company. Despite a very volatile environment, we have been able to generate a reasonable growth in revenue along with a much-improved bottom line. We remain cautiously optimistic about the future.

Informational and educational content only. Not investment advice.